已收盘 09-25 16:00:00 美东时间
0.000
0.00%
Hafnia (HAFN) falls 6.6% pre-market Thursday after saying it completed its previously announced $300M equity placement, seeking to strengthen its balance sheet following its acquisition of TORM (TRMD)...
09-24 20:55
Hafnia shares are trading lower after the company announced it will purchase an additional 1.7 million TORM shares at $34.00 each.
09-24 19:57
今日重点评级关注:康托·菲茨杰拉德:维持Abeona Therapeutics"超配"评级,目标价从28美元升至30美元;HC Wainwright & Co.:维持Oculis Holding"买入"评级,目标价从26美元升至39美元
09-21 16:25
BTIG analyst Gregory Lewis maintains Hafnia (NYSE:HAFN) with a Buy and raises the price target from $10 to $12.
09-18 17:46
On Friday, Hafnia (NYSE:HAFN) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. Vi...
09-18 17:27
HELLERUP, Denmark, Sept. 18, 2026 /PRNewswire/ -- Pursuant to section 30 of the Danish Capital Markets Act, TORM plc (NASDAQ: TRMD) (NASDAQ: TRMD A) hereby announces that: Hafnia Limited ("...
09-18 17:23
TORM plc (TRMD) has announced the closing of its previously disclosed secondary public offering of 9M Class A common shares. The shares were sold by OCM Njord Holdings S.à r.l., an entity indirectly o...
09-17 14:12
Oil product tanker TORM (TRMD) jumped 6.5% to a more-than-two-year high in Wednesday's trading after tanker peer Hafnia (HAFN) agreed to acquire 4.5M shares for $145M from OaktreeCapital Management, m...
09-17 00:32
Hafnia Limited (NYSE:HAFN) shares rose Wednesday in premarket trading after the tanker operator agreed to acquire an additional 4.5 million shares of TORM plc (NASDAQ:TRMD). S&P 500 futures were up about 0.2%, while Nasdaq futures also pointed higher. Hafnia Raises TORM Stake To 18.22% Hafnia agreed...
09-16 18:18
U.S. stock futures were lower this morning, with the Dow futures falling over 400 points on Tuesday. Shares of Novartis AG (NYSE:NVS) fell sharply in pre-market trading after the company disclosed that the pelacarsen phase III Lp(a) HORIZON trial did not meet its primary endpoint. Novartis shares tu...
09-08 20:01